ArticlePharmaceutical medicine2019

Biosimilars in the USA: Will New Efforts to Spur Approvals and Access Spur Uptake and Cost Savings?

Stanton R Mehr et al.PubMed ↗Publisher ↗

No numbers read from the abstract.